Zachary Roberts - 21 Jan 2026 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role: EVP of R&D
Signature: /s/Earl Douglas, Attorney-in-Fact
Issuer symbol: ALLO
Transactions as of: 21 Jan 2026
Net transactions value: -$40,980
Form type: 4
Filing time: 23 Jan 2026, 16:15:10 UTC
Previous filing: 05 Feb 2025
Next filing: 04 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Roberts Zachary	EVP of R&D	210 EAST GRAND AVE, SOUTH SAN FRANCISCO	/s/Earl Douglas, Attorney-in-Fact	23 Jan 2026	0001851044

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALLO	Common Stock	Sale	$40,980	-26,269	-4.1%	$1.56	616,866	21 Jan 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Content

Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.